Sliding Scale Insulin Should NOT Be Used Alone in Hospitalized Patients with Diabetes
Sliding scale insulin (SSI) as monotherapy is strongly discouraged for hospitalized patients with known diabetes and should be replaced with scheduled basal-bolus or basal-only insulin regimens. 1, 2
Why Sliding Scale Insulin Fails
SSI is a reactive approach that treats hyperglycemia after it occurs rather than preventing it. This strategy is associated with:
- Clinically significant hyperglycemia in most patients 1
- 3-fold higher risk of hyperglycemic episodes compared to no pharmacologic treatment when used alone 3
- No improvement in glycemic control versus routine diabetes medications 4
- Higher mean glucose levels (20 mg/dL higher) compared to other insulin strategies 5
The evidence is clear: SSI alone provides no benefit and worsens outcomes 3.
When SSI May Be Acceptable (Limited Scenarios)
SSI alone may be appropriate ONLY for:
- Patients WITHOUT pre-existing diabetes who develop mild stress hyperglycemia 1
- Never in type 1 diabetes - these patients require basal insulin at minimum 1
The Preferred Approach: Scheduled Insulin Regimens
For Most Hospitalized Patients with Type 2 Diabetes:
Basal-Bolus Regimen (first-line for moderate-severe hyperglycemia):
- Calculate total daily dose: 0.3-0.5 units/kg/day for insulin-naive patients 1
- Split 50/50: half as basal insulin (once or twice daily), half as rapid-acting insulin (divided before three meals) 1
- Add correctional (supplemental) rapid-acting insulin on top of scheduled doses 2
- Reduces postoperative complications (wound infection, pneumonia, bacteremia, renal/respiratory failure) compared to SSI alone 1
Lower doses (0.1-0.25 units/kg/day) for high-risk patients:
- Age >65 years
- Renal failure
- Poor oral intake 1
For Mild Hyperglycemia or Reduced Oral Intake:
Basal-Plus Regimen (simpler alternative):
- Single daily basal insulin dose: 0.1-0.25 units/kg/day 1
- Add correctional rapid-acting insulin before meals or every 6 hours if NPO 1
- More favorable hyperglycemia profile than SSI in real-world practice 6
How to Administer Correctional (Supplemental) Insulin
When correctional insulin IS used (as part of scheduled regimens, not alone):
- Administer rapid-acting or short-acting insulin subcutaneously 1
- Give before meals or every 6 hours if patient is NPO 1
- Dose based on current blood glucose above target
- Monitor blood glucose at least every 2-4 hours while NPO 2
Adjustment Strategy
Daily insulin adjustment is critical - yet 65% of patients with hyper/hypoglycemia receive no insulin order changes in the first 5 days 5. This is a major pitfall.
Systematic titration approach:
- Check fasting and pre-meal glucose daily
- Adjust basal insulin based on fasting glucose
- Adjust prandial insulin based on pre-meal and 2-hour post-meal glucose
- Titrate every 2-3 days until targets reached (100-180 mg/dL) 2
Critical Pitfalls to Avoid
- Never use SSI alone in patients with known diabetes - this is the most common error 1, 3
- Avoid premixed insulin (70/30) in hospital - unacceptably high hypoglycemia rates 1
- Do not mix or dilute insulin preparations 7
- Rotate injection sites within same region to prevent lipodystrophy 7
- Reduce home insulin dose by 20% on admission if patient was on ≥0.6 units/kg/day to prevent hypoglycemia with reduced oral intake 1
Special Considerations
Transitioning from IV insulin:
- Give subcutaneous basal insulin 2-4 hours before stopping IV insulin to prevent rebound hyperglycemia and ketoacidosis 2
- Estimate daily subcutaneous dose from average hourly IV rate × 24 hours (e.g., 1.5 units/hour = 36 units/day total) 1
Perioperative management:
- Hold metformin day of surgery
- Stop SGLT2 inhibitors 3-4 days before surgery
- Give 50% of NPH or 75-80% of long-acting insulin dose 2
The evidence overwhelmingly supports abandoning SSI monotherapy in favor of scheduled, physiologic insulin regimens that prevent rather than react to hyperglycemia.